Complement Activation in Relation to Capillary Leakage in Children with Septic Shock and Purpura

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Infection and Immunity

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/IAI.66.11.5350-5356.1998PMID 9784543PMCID PMC108669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation

  1997cited by this paper
• COMPLEMENT ACTIVATION IN CHILDREN WITH SEPTIC SHOCK AND PURPURA (SSP): CLASSICAL OR ALTERNATIVE PATHWAY.: 292

  1997cited by this paper
• Age-related Differences in Outcome and Severity of DIC in Children with Septic Shock and Purpura

  1996cited by this paper
• TNF-alpha suppresses IL-1 alpha and IL-6 upregulation of C4b-binding protein in HepG-2 hepatoma cells.

  1996cited by this paper
• TNF-α suppresses IL-1α and IL-6 upregulation of C4b-binding protein in HepG-2 hepatoma cells

  1996cited by this paper
• A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP.

  1996cited by this paper
• CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes.

  1996cited by this paper
• The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation.

  1996cited by this paper
• Binding of Complement Proteins C1q and C4bp to Serum Amyloid P Component (SAP) in Solid Contra Liquid Phase

  1996cited by this paper
• Systemic meningococcal disease: Clinical pictures and pathophysiological background

  1996cited by this paper
• Therapy with interleukin-2 induces the systemic release of phospholipase-A2

  1995cited by this paper
• Endothelial cell‐to‐cell junctions

  1995cited by this paper
• The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure.

  1995cited by this paper
• Group II phospholipase A2 in serum in critically ill surgical patients

  1994cited by this paper
• Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.

  1994cited by this paper
• Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern

  1993cited by this paper
• Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway.

  1993cited by this paper
• Complement deficiency states and meningococcal disease

  1993cited by this paper
• Endothelial cell-to-cell junctions. Structural characteristics and functional role in the regulation of vascular permeability and leukocyte extravasation.

  1993cited by this paper
• Low Prevalence of Complement Deficiencies among Patients with Meningococcal Disease in Norway

  1993cited by this paper
• Influence of C1-inhibitor on inflammation, edema and shock.

  1993cited by this paper
• Inhibitors of complement and neutrophils: A critical evaluation of their role in the treatment of sepsis

  1992cited by this paper
• Interplay of complement and cytokines in the pathogenesis of septic shock.

  1992cited by this paper
• Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.

  1992cited by this paper
• Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin

  1992cited by this paper
• Role of the Complement Cascade in Severe Sepsis

  1992cited by this paper
• C4b-binding protein exacerbates the host response to Escherichia coli.

  1991cited by this paper
• Protein C, Protein S and c4b-Binding Protein in Severe lnfection and Septic Shock

  1991cited by this paper
• Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.

  1989cited by this paper
• Neutrophil-mediated vascular injury in shock and multiple organ failure.

  1989cited by this paper
• Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae

  1989cited by this paper
• Complement activation and endotoxin levels in systemic meningococcal disease.

  1989cited by this paper
• Proteolytic inactivation of plasma C1- inhibitor in sepsis.

  1989influential reference
• A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a.

  1988cited by this paper
• Pediatric risk of mortality (PRISM) score.

  1988cited by this paper
• Mediators of Sepsis

  1987cited by this paper
• Complement abnormalities during an epidemic of group B meningococcal infection in children.

  1986cited by this paper
• Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

  1986cited by this paper
• A rate nephelometer for measuring specific proteins by immunoprecipitin reactions.

  1977cited by this paper

• Infection at the Vascular Front: A Delicate Balance Between Defense and Pathology.

  2025cites this paper
• Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients

  2021influential citation
• Complement Component 3 Is Required for Tissue Damage, Neutrophil Infiltration, and Ensuring NET Formation in Acute Pancreatitis

  2021cites this paper
• Childhood Obesity, Endothelial Cell Activation, and Critical Illness

  2020cites this paper
• Complement in Sepsis - when Science meets Clinics.

  2020cites this paper
• Circulating Complement C3-Alpha Chain Levels Predict Survival of Septic Shock Patients.

  2019cites this paper
• Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis

  2019cites this paper
• НОВЫЕ АСПЕКТЫ ПАТОГЕНЕЗА СЕПСИСА И СЕПТИЧЕСКОГО ШОКА У ДЕТЕЙ. СИСТЕМА КОМПЛЕМЕНТА КАК МИШЕНЬ ДЛЯ ЭФФЕКТИВНОЙ ТЕРАПИИ

  2018cites this paper
• High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study

  2018cites this paper
• Complement as a diagnostic tool in immunopathology.

  2018cites this paper
• Janus face of complement-driven neutrophil activation during sepsis.

  2018cites this paper
• Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions

  2017cites this paper
• Endothelial Cell Function and Dysfunction in Critically Ill Children

  2017cites this paper
• Complement as a Diagnostic tool

  2017cites this paper
• EXTRAVASCULAR LUNG WATER IS A PREDICTOR OF DEVELOPMENT OF MULTIPLE ORGAN FAILURE IN CHILDREN WITH SEVERE BURN INJURY.

  2017cites this paper
• Clofarabine associated capillary leak syndrome in a child with lymphoma successfully treated with intravenous immunoglobulin.

  2015cites this paper
• Las bases genéticas de la susceptibilidad a la enfermedad meningocócica

  2015cites this paper
• Activated Complement Factors as Disease Markers for Sepsis

  2015cites this paper
• HIV Coinfection Enhances Complement Activation During Sepsis.

  2015cites this paper
• The prognostic performance of the complement system in septic patients in emergency department: a cohort study.

  2015cites this paper
• Severe sepsis Epidemiology and sex-related differences in inflammatory markers.

  2014cites this paper
• Multiple Organ Dysfunction Syndrome

  2014cites this paper
• family with meningococcal infections a deficiency by two novel mutations in the Complement Factor D gene in Deficient alternative complement pathway activation due to factor D

  2013cites this paper
• The Role of Complement System in Septic Shock

  2012cites this paper
• Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza

  2011cites this paper
• Neisseria meningitidis Opc Invasin Binds to the Sulphated Tyrosines of Activated Vitronectin to Attach to and Invade Human Brain Endothelial Cells

  2010cites this paper
• C1 inhibitor level on neonatal sepsis and its relations with clinical findings

  2010cites this paper
• The pediatric multiple organ dysfunction syndrome

  2009cites this paper
• Extravascular lung water measurement using transpulmonary thermodilution in children

  2009cites this paper
• Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.

  2009cites this paper
• Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?

  2008cites this paper
• Chapter 8 – Circulatory Emergencies: Shock

  2008cites this paper
• Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.

  2008cites this paper
• Polymorphisms in Immune Response Genes in Infectious Diseases and Autoimmune Diseases

  2008cites this paper
• Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children

  2008cites this paper
• Infectious Diseases in the Pediatric Intensive Care Unit

  2008cites this paper
• Stages of Meningococcal Sepsis Simulated In Vitro, with Emphasis on Complement and Toll-Like Receptor Activation

  2008cites this paper
• Interactions between Neisseria meningitidis and the complement system.

  2007cites this paper
• Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

  2007cites this paper
• Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections.

  2006cites this paper
• Hypertonic-Hyperoncotic Solutions Improve Cardiac Function in Children After Open-Heart Surgery

  2006cites this paper
• Meningococcal infections at the start of the 21st century.

  2005cites this paper
• Hémodynamique non invasive et approche thérapeutique du choc septique chez l'enfant

  2005cites this paper
• Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis 1

  2005cites this paper
• Fluid balance in acute lung injury: a model of clinical trial development.

  2005cites this paper
• C1 inhibitor: molecular and clinical aspects

  2005cites this paper
• VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED DURING THE FIRST 48 HOURS OF HUMAN SEPTIC SHOCK AND CORRELATES WITH VASCULAR PERMEABILITY

  2005cites this paper
• Pathogenesis of Neisseria meningitidis : a review of current understanding

  2005cites this paper
• C 5 a Receptor Expression in Severe Sepsis and Septic Shock

  2005cites this paper
• Elastase and granzymes during meningococcal disease in children: correlation to disease severity

  2005cites this paper
• C5a Receptor Expression in Severe Sepsis and Septic Shock

  2005cites this paper
• Myocardial dysfunction in meningococcal septic shock: no clear answer yet.

  2005cites this paper
• Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide

  2004cites this paper
• Genetische factoren van de gastheer in infecties met Neisseria meningitidis

  2004cites this paper
• Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas

  2004cites this paper
• Activation of multiple signaling pathways by terminal complement complexes involved in myocellular sodium homeostasis.

  2004influential citation
• Interactions of soluble complement regulators with pathogenic bacteria

  2004influential citation
• Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

  2003cites this paper
• Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis

  2003cites this paper
• The immunopathogenesis of meningococcal disease

  2003cites this paper
• Association of Protein-losing Enteropathy and Cryoglobulinaemia

  2003cites this paper
• Severe meningococcal disease in childhood.

  2003cites this paper
• Host genetic determinants of Neisseria meningitidis infections.

  2003cites this paper
• Thrombin Avtivable Fibrinolysis Inhibitor in Venous and Arterial Thrombosis

  2003cites this paper
• Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant.

  2002cites this paper
• Meningococcal disease: treatment and prevention

  2002cites this paper
• Emergency department dermatology

  2002cites this paper
• Increased Production of Interleukin-8 in Primary Human Monocytes and in Human Epithelial and Endothelial Cell Lines after Dengue Virus Challenge

  2002cites this paper
• Evaluation of lipopolysaccharide-induced activation of equine neutrophils.

  2002cites this paper
• Complement activation alters myocellular sodium homeostasis during polymicrobial sepsis.

  2002cites this paper
• Does endotoxin-activated complement alter myocellular sodium homeostasis during sepsis?

  2002cites this paper
• Invited review: Neisseria meningitidis lipopolysaccharides in human pathology

  2001cites this paper
• Neisseria meningitidis lipopolysaccharides in human pathology.

  2001cites this paper
• Meningococcal disease--some issues in treatment.

  2001cites this paper
• Targeting complement in therapy

  2001cites this paper
• Humoral markers of severity and prognosis of critical illness.

  2001cites this paper
• Maintenance of Blood Flow Is Essential

  2001cites this paper
• In vitro complement activation favoring soluble C5b-9 complex formation alters myocellular sodium homeostasis.

  2001cites this paper
• Diffuse non-hydrostatic, non-hypooncotic edema in autoimmune lupus-like disorders.

  2001cites this paper
• Can generic scores (Pediatric Risk of Mortality and Pediatric Index of Mortality) replace specific scores in predicting the outcome of presumed meningococcal septic shock in children?

  2001cites this paper
• Cytokines, chemokines and other effector molecules involved in meningococcal disease.

  2001cites this paper
• Improving the outcome of septic shock in children.

  2000cites this paper
• Update on meningococcal disease with emphasis on pathogenesis and clinical management.

  2000influential citation
• Therapeutic Complement Inhibition

  2000cites this paper
• Sublytic complement attack increases intracellular sodium in rat skeletal muscle.

  2000cites this paper
• Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management

  2000influential citation
• Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation

  1999cites this paper
• Metabolic, endocrine and nutritional aspects of critically ill children

  1999cites this paper
• Mechanisms of neisserial serum resistance

  1999cites this paper